SEC Form 4 · accession 0000874015-19-000022
IONIS PHARMACEUTICALS INC · IONS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stanley T Crooke
Officer — Chairman and CEO · Director
Period of report
Jan 15, 2019
Accepted (ET)
Jan 17, 2019 · 7:27 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000874015
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 15, 2019 | M | 30,587 | $0.00 | A | 82,320 | D | |
| Common StockF2 | Jan 15, 2019 | F | 12,686 | $58.26 | D | 69,634 | D | |
| Common StockF1 | Jan 15, 2019 | M | 2,346 | $0.00 | A | 6,474 | I | By wife |
| Common StockF2 | Jan 15, 2019 | F | 942 | $58.26 | D | 5,532 | I | By wife |
| Common Stock | holding | — | — | — | 725,391 | I | By trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF3,F4,F5 | — | Jan 15, 2019 | A | 63,726 | A | — | — | Common Stock | 63,726 | 63,726 | D |
| Restricted Stock UnitsF4,F6,F5 | — | Jan 15, 2019 | A | 5,332 | A | — | — | Common Stock | 5,332 | 5,332 | I |
| Restricted Stock UnitsF4,F5 | — | Jan 15, 2019 | M | 30,587 | D | — | — | Common Stock | 30,587 | 48,077 | D |
| Restricted Stock UnitsF4,F5 | — | Jan 15, 2019 | M | 2,346 | D | — | — | Common Stock | 2,346 | 4,612 | I |
Explanation of responses
- F1Acquired pursuant to vesting and release of shares pursuant to Restricted Stock Unit awards.
- F2Shares withheld to cover the required tax withholding obligations pursuant to the 2011 Equity Incentive Plan Restricted Stock Unit Agreement and Grant Notice.
- F3Grant to reporting person of Restricted Stock Units under the Ionis Pharmaceuticals, Inc. 2011 Equity Incentive Plan.
- F4Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value.
- F5Restricted Stock Units vest in four equal annual installments. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company.
- F6Grant to reporting person's wife of Restricted Stock Units under the Ionis Pharmaceuticals, Inc. 2011 Equity Incentive Plan.